Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain.

We report the synthesis and in vitro antimalarial activity of several new 4-amino- and 4-alkoxy-7-chloroquinolines carrying a linear dibasic side chain. Many of these chloroquine analogues have submicromolar antimalarial activity versus HB3 (chloroquine sensitive) and Dd2 (chloroquine resistant strain of Plasmodium falciparum) and low resistance indices were obtained in most cases. Importantly, compounds 11-15 and 24 proved to be more potent against Dd2 than chloroquine. Branching of the side chain structure proved detrimental to the activity against the CQR strain.

[1]  Robert G. Ridley,et al.  Medical need, scientific opportunity and the drive for antimalarial drugs , 2002, Nature.

[2]  S. Parapini,et al.  Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. , 2002, Journal of medicinal chemistry.

[3]  P. Roepe,et al.  Structure of the amodiaquine-FPIX mu oxo dimer solution complex at atomic resolution. , 2004, Inorganic chemistry.

[4]  S. Maiti,et al.  Carbon isosteres of the 4-aminopyridine substructure of chloroquine: effects on pK(a), hematin binding, inhibition of hemozoin formation, and parasite growth. , 2003, Journal of medicinal chemistry.

[5]  S. Hay,et al.  The global distribution of clinical episodes of Plasmodium falciparum malaria , 2005, Nature.

[6]  K. Mendis,et al.  The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.

[7]  P. Roepe,et al.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. , 2009, Bioorganic & medicinal chemistry.

[8]  T. Egan,et al.  Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. , 2000, Journal of medicinal chemistry.

[9]  S. Kappe,et al.  Malaria: progress, perils, and prospects for eradication. , 2008, The Journal of clinical investigation.

[10]  H. Ginsburg,et al.  Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. , 1986, Biochemical pharmacology.

[11]  C. Chong,et al.  Inhibition of heme crystal growth by antimalarials and other compounds: implications for drug discovery. , 2003, Biochemical pharmacology.

[12]  P. Roepe,et al.  Solution structures of antimalarial drug-heme complexes. , 2002, Biochemistry.

[13]  I. Robinson,et al.  Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs. , 2007, Journal of the American Chemical Society.

[14]  H. Matile,et al.  4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum , 1996, Antimicrobial agents and chemotherapy.

[15]  D. Krogstad,et al.  Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. , 1996, The American journal of tropical medicine and hygiene.

[16]  Peter W. Stephens,et al.  The structure of malaria pigment β-haematin , 2000, Nature.

[17]  P. Roepe,et al.  Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines. , 2008, Journal of medicinal chemistry.

[18]  P. Roepe,et al.  NMR Studies of Chloroquine-Ferriprotoporphyrin IX Complex , 2003 .

[19]  D. Krogstad,et al.  ANTIMALARIALS : SYNTHESIS OF 4-AMINOQUINOLINES THAT CIRCUMVENT DRUG RESISTANCE IN MALARIA PARASITES , 1997 .

[20]  P. Roepe,et al.  Novel, Rapid, and Inexpensive Cell-Based Quantification of Antimalarial Drug Efficacy , 2004, Antimicrobial Agents and Chemotherapy.

[21]  B. K. Park,et al.  4-Aminoquinolines--past, present, and future: a chemical perspective. , 1998, Pharmacology & therapeutics.

[22]  L. Gerena,et al.  Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening , 2007, Antimicrobial Agents and Chemotherapy.

[23]  I W Sherman,et al.  Amino acid metabolism and protein synthesis in malarial parasites. , 1977, Bulletin of the World Health Organization.

[24]  P. Wilairat,et al.  Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening , 2004, Antimicrobial Agents and Chemotherapy.

[25]  B. K. Park,et al.  Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. , 2002, Journal of medicinal chemistry.

[26]  P. Roepe,et al.  4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria. , 2008, Journal of medicinal chemistry.